Comparison Between Ondansetron 8 mg and Lidocain 40 mg in Preventing Pain Due to Propofol Injection

NCT ID: NCT03134612

Last Updated: 2017-05-01

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

PHASE2

Total Enrollment

104 participants

Study Classification

INTERVENTIONAL

Study Start Date

2016-07-31

Study Completion Date

2016-09-30

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

This study aims to compare the effectivity between ondansetron 8 mg and lidocain 40 mg in preventing pain due to propofol injection

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Approval from Ethical Committee of Faculty of Medicine Universitas Indonesia was acquired prior conducting the study. Subjects were given informed consent before enrolling the study. Non-invasive blood pressure (NIBP) monitor, ECG and pulse-oximeter was set on the subjects in the operation room. After a tourniquet made from NIBP cuff were inflated, subjects were given either Ondansetron 8 mg or Lidocain 20 mg intravenously, then the tourniquet was set off. Hemodynamic data was recorded. Propofol 1 mg/kg of body weight (BW) injection was given. Verbal rating scale was used to measure pain at 0 s, 5 s and 30 s. Data was analyzed using Statistical Package for the Social Sciences (SPSS), for numeric data using uni-variate analysis and bi-variate analysis. Significant value is p\<0.05.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

General Anesthesia With Propofol

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

SUPPORTIVE_CARE

Blinding Strategy

DOUBLE

Participants Caregivers

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Ondansetron

Ondansetron 8mg (2mg/cc) was given intravenously via a 20 G vein canula

Group Type ACTIVE_COMPARATOR

Ondansetron 8 mg

Intervention Type DRUG

Lidocain

Lidocain 40mg (20mg/cc + 2cc of normal saline) was given intravenously via a 20 G vein canula

Group Type ACTIVE_COMPARATOR

Lidocain 40 mg

Intervention Type DRUG

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Ondansetron 8 mg

Intervention Type DRUG

Lidocain 40 mg

Intervention Type DRUG

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Subjects aged 18-65 years old
* Subjects were planned to undergo general anesthesia with propofol
* Subjects with Body Mass Index (BMI) 18-35 kg/m2
* Subjects with American Society of Anesthesiologists (ASA) physical status of I-II
* Subjects with signed informed consent.

Exclusion Criteria

* Subjects with allergies to propofol, lidocain, ondansetron
* Subjects with massive cardiac disorder
* Subjects with cardiac rhythm disorder with or without treatment
* Subjects with unstable hemodynamic
* Subjects with contraindication to propofol, lidocain, ondansetron
* Subjects with intubation and ventilation difficulty
* Subjects with decreased consciousness, seizure history or head injury
* Subjects with analgesic treatment history
* Subjects with pregnancy.

Drop out criteria:

* Subjects with allergic reactions induced by propofol, lidocain, ondansetron
* Uncooperative subjects
* Subjects in emergency
* Subjects with difficult vein access in the dorsum manus
* Subjects with infection and/or inflammation in the planned intravenous cannulation location.
Minimum Eligible Age

18 Years

Maximum Eligible Age

65 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Indonesia University

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Aries Perdana

Consultant, Anesthesiologist

Responsibility Role PRINCIPAL_INVESTIGATOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Aries Perdana, Consultant

Role: PRINCIPAL_INVESTIGATOR

Indonesia University

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Cipto Mangunkusumo Central National Hospital

Jakarta, DKI Jakarta, Indonesia

Site Status

Countries

Review the countries where the study has at least one active or historical site.

Indonesia

References

Explore related publications, articles, or registry entries linked to this study.

Marik PE. Propofol: therapeutic indications and side-effects. Curr Pharm Des. 2004;10(29):3639-49. doi: 10.2174/1381612043382846.

Reference Type BACKGROUND
PMID: 15579060 (View on PubMed)

Jalota L, Kalira V, George E, Shi YY, Hornuss C, Radke O, Pace NL, Apfel CC; Perioperative Clinical Research Core. Prevention of pain on injection of propofol: systematic review and meta-analysis. BMJ. 2011 Mar 15;342:d1110. doi: 10.1136/bmj.d1110.

Reference Type BACKGROUND
PMID: 21406529 (View on PubMed)

Tan CH, Onsiong MK. Pain on injection of propofol. Anaesthesia. 1998 May;53(5):468-76. doi: 10.1046/j.1365-2044.1998.00405.x.

Reference Type BACKGROUND
PMID: 9659020 (View on PubMed)

Johnson RA, Harper NJ, Chadwick S, Vohra A. Pain on injection of propofol. Methods of alleviation. Anaesthesia. 1990 Jun;45(6):439-42. doi: 10.1111/j.1365-2044.1990.tb14328.x.

Reference Type BACKGROUND
PMID: 2200299 (View on PubMed)

Macario A, Weinger M, Truong P, Lee M. Which clinical anesthesia outcomes are both common and important to avoid? The perspective of a panel of expert anesthesiologists. Anesth Analg. 1999 May;88(5):1085-91. doi: 10.1097/00000539-199905000-00023.

Reference Type BACKGROUND
PMID: 10320175 (View on PubMed)

Ye JH, Mui WC, Ren J, Hunt TE, Wu WH, Zbuzek VK. Ondansetron exhibits the properties of a local anesthetic. Anesth Analg. 1997 Nov;85(5):1116-21. doi: 10.1097/00000539-199711000-00029.

Reference Type BACKGROUND
PMID: 9356111 (View on PubMed)

Lee SK. Pain on injection with propofol. Korean J Anesthesiol. 2010 Nov;59(5):297-8. doi: 10.4097/kjae.2010.59.5.297. Epub 2010 Nov 25. No abstract available.

Reference Type BACKGROUND
PMID: 21179288 (View on PubMed)

Massad IM, Abu-Ali HM, Abu-Halaweh SA, Badran IZ. Venous occlusion with lidocaine for preventing propofol induced pain. A prospective double-blind randomized study. Saudi Med J. 2006 Jul;27(7):997-1000.

Reference Type BACKGROUND
PMID: 16830018 (View on PubMed)

Picard P, Tramer MR. Prevention of pain on injection with propofol: a quantitative systematic review. Anesth Analg. 2000 Apr;90(4):963-9. doi: 10.1097/00000539-200004000-00035.

Reference Type BACKGROUND
PMID: 10735808 (View on PubMed)

Mangar D, Holak EJ. Tourniquet at 50 mm Hg followed by intravenous lidocaine diminishes hand pain associated with propofol injection. Anesth Analg. 1992 Feb;74(2):250-2. doi: 10.1213/00000539-199202000-00014.

Reference Type BACKGROUND
PMID: 1731546 (View on PubMed)

Gan TJ, Diemunsch P, Habib AS, Kovac A, Kranke P, Meyer TA, Watcha M, Chung F, Angus S, Apfel CC, Bergese SD, Candiotti KA, Chan MT, Davis PJ, Hooper VD, Lagoo-Deenadayalan S, Myles P, Nezat G, Philip BK, Tramer MR; Society for Ambulatory Anesthesia. Consensus guidelines for the management of postoperative nausea and vomiting. Anesth Analg. 2014 Jan;118(1):85-113. doi: 10.1213/ANE.0000000000000002.

Reference Type BACKGROUND
PMID: 24356162 (View on PubMed)

Tramer MR, Reynolds DJ, Moore RA, McQuay HJ. Efficacy, dose-response, and safety of ondansetron in prevention of postoperative nausea and vomiting: a quantitative systematic review of randomized placebo-controlled trials. Anesthesiology. 1997 Dec;87(6):1277-89. doi: 10.1097/00000542-199712000-00004.

Reference Type BACKGROUND
PMID: 9416710 (View on PubMed)

Paventi S, Santevecchi A, Ranieri R. Efficacy of a single-dose ondansetron for preventing post-operative nausea and vomiting after laparoscopic cholecystectomy with sevoflurane and remifentanil infusion anaesthesia. Eur Rev Med Pharmacol Sci. 2001 Mar-Apr;5(2):59-63.

Reference Type BACKGROUND
PMID: 11863320 (View on PubMed)

Azimaraghi O, Aghajani Y, Molaghadimi M, Khosravi M, Eslami K, Ghadimi F, Movafegh A. Ondansetrona reduz a dor da injecao de etomidato: estudo randomico controlado. Braz J Anesthesiol. 2014 May-Jun;64(3):169-72. doi: 10.1016/j.bjan.2013.06.014. Epub 2014 Mar 7. No abstract available. Portuguese.

Reference Type BACKGROUND
PMID: 25456475 (View on PubMed)

Ambesh SP, Dubey PK, Sinha PK. Ondansetron pretreatment to alleviate pain on propofol injection: a randomized, controlled, double-blinded study. Anesth Analg. 1999 Jul;89(1):197-9. doi: 10.1097/00000539-199907000-00035.

Reference Type BACKGROUND
PMID: 10389803 (View on PubMed)

Zahedi H, Maleki A, Rostami G. Ondansetron pretreatment reduces pain on injection of propofol. Acta Med Iran. 2012;50(4):239-43.

Reference Type BACKGROUND
PMID: 22592573 (View on PubMed)

Powell RM, Buggy DJ. Ondansetron given before induction of anesthesia reduces shivering after general anesthesia. Anesth Analg. 2000 Jun;90(6):1423-7. doi: 10.1097/00000539-200006000-00032.

Reference Type BACKGROUND
PMID: 10825334 (View on PubMed)

Yeh HM, Chen LK, Lin CJ, Chan WH, Chen YP, Lin CS, Sun WZ, Wang MJ, Tsai SK. Prophylactic intravenous ondansetron reduces the incidence of intrathecal morphine-induced pruritus in patients undergoing cesarean delivery. Anesth Analg. 2000 Jul;91(1):172-5. doi: 10.1097/00000539-200007000-00032.

Reference Type BACKGROUND
PMID: 10866907 (View on PubMed)

Kyriakides K, Hussain SK, Hobbs GJ. Management of opioid-induced pruritus: a role for 5-HT3 antagonists? Br J Anaesth. 1999 Mar;82(3):439-41. doi: 10.1093/bja/82.3.439.

Reference Type BACKGROUND
PMID: 10434832 (View on PubMed)

Ye JH, Ponnudurai R, Schaefer R. Ondansetron: a selective 5-HT(3) receptor antagonist and its applications in CNS-related disorders. CNS Drug Rev. 2001 Summer;7(2):199-213. doi: 10.1111/j.1527-3458.2001.tb00195.x.

Reference Type BACKGROUND
PMID: 11474424 (View on PubMed)

Golparvar M, Saghaei M, Saadati MA, Farsaei S. Effect of ondansetron on prevention of post-induction hypotension in elderly patients undergoing general anesthesia: A randomized, double-blind placebo-controlled clinical trial. Saudi J Anaesth. 2015 Oct-Dec;9(4):365-9. doi: 10.4103/1658-354X.159455.

Reference Type BACKGROUND
PMID: 26543450 (View on PubMed)

Reddy MS, Chen FG, Ng HP. Effect of ondansetron pretreatment on pain after rocuronium and propofol injection: a randomised, double-blind controlled comparison with lidocaine. Anaesthesia. 2001 Sep;56(9):902-5. doi: 10.1046/j.1365-2044.2001.02059-6.x.

Reference Type BACKGROUND
PMID: 11531681 (View on PubMed)

Bolton CM, Myles PS, Carlin JB, Nolan T. Randomized, double-blind study comparing the efficacy of moderate-dose metoclopramide and ondansetron for the prophylactic control of postoperative vomiting in children after tonsillectomy. Br J Anaesth. 2007 Nov;99(5):699-703. doi: 10.1093/bja/aem236. Epub 2007 Aug 21.

Reference Type BACKGROUND
PMID: 17715139 (View on PubMed)

Deegan R. Ondansetron: pharmacology of a specific 5HT3-receptor antagonist. Am J Med Sci. 1992 Dec;304(6):373-8. doi: 10.1097/00000441-199212000-00009. No abstract available.

Reference Type BACKGROUND
PMID: 1456277 (View on PubMed)

Brill S, Middleton W, Brill G, Fisher A. Bier's block; 100 years old and still going strong! Acta Anaesthesiol Scand. 2004 Jan;48(1):117-22. doi: 10.1111/j.1399-6576.2004.00280.x.

Reference Type BACKGROUND
PMID: 14674982 (View on PubMed)

van Zundert A, Helmstadter A, Goerig M, Mortier E. Centennial of intravenous regional anesthesia. Bier's Block (1908-2008). Reg Anesth Pain Med. 2008 Sep-Oct;33(5):483-9. doi: 10.1016/j.rapm.2008.04.011.

Reference Type BACKGROUND
PMID: 18774520 (View on PubMed)

Rosenberg PH, Heavner JE. Multiple and complementary mechanisms produce analgesia during intravenous regional anesthesia. Anesthesiology. 1985 Jun;62(6):840-2. No abstract available.

Reference Type BACKGROUND
PMID: 4003822 (View on PubMed)

Shevchenko Y, Jocson JC, McRae VA, Stayer SA, Schwartz RE, Rehman M, Choudhry DK. The use of lidocaine for preventing the withdrawal associated with the injection of rocuronium in children and adolescents. Anesth Analg. 1999 Apr;88(4):746-8. doi: 10.1097/00000539-199904000-00011.

Reference Type BACKGROUND
PMID: 10195516 (View on PubMed)

Memis D, Turan A, Karamanlioglu B, Kaya G, Pamukcu Z. The prevention of propofol injection pain by tramadol or ondansetron. Eur J Anaesthesiol. 2002 Jan;19(1):47-51. doi: 10.1017/s0265021502000078.

Reference Type BACKGROUND
PMID: 11913803 (View on PubMed)

Mahler SA, Massey G, Meskill L, Wang H, Arnold TC. Can we make the basilic vein larger? maneuvers to facilitate ultrasound guided peripheral intravenous access: a prospective cross-sectional study. Int J Emerg Med. 2011 Aug 25;4:53. doi: 10.1186/1865-1380-4-53.

Reference Type BACKGROUND
PMID: 21867495 (View on PubMed)

Groothuis JT, van Vliet L, Kooijman M, Hopman MT. Venous cuff pressures from 30 mmHg to diastolic pressure are recommended to measure arterial inflow by plethysmography. J Appl Physiol (1985). 2003 Jul;95(1):342-7. doi: 10.1152/japplphysiol.00022.2003. Epub 2003 Apr 4.

Reference Type BACKGROUND
PMID: 12679358 (View on PubMed)

Flaherty SA. Pain measurement tools for clinical practice and research. AANA J. 1996 Apr;64(2):133-40.

Reference Type BACKGROUND
PMID: 9095685 (View on PubMed)

Williamson A, Hoggart B. Pain: a review of three commonly used pain rating scales. J Clin Nurs. 2005 Aug;14(7):798-804. doi: 10.1111/j.1365-2702.2005.01121.x.

Reference Type BACKGROUND
PMID: 16000093 (View on PubMed)

McCrirrick A, Hunter S. Pain on injection of propofol: the effect of injectate temperature. Anaesthesia. 1990 Jun;45(6):443-4. doi: 10.1111/j.1365-2044.1990.tb14329.x.

Reference Type BACKGROUND
PMID: 2200300 (View on PubMed)

Aubrun F, Paqueron X, Langeron O, Coriat P, Riou B. What pain scales do nurses use in the postanaesthesia care unit? Eur J Anaesthesiol. 2003 Sep;20(9):745-9. doi: 10.1017/s0265021503001212.

Reference Type BACKGROUND
PMID: 12974598 (View on PubMed)

Study Documents

Access uploaded study-related documents such as protocols, statistical analysis plans, or lay summaries.

Document Type: Textbook

Assessment and measurement of pain and its treatment. In: Macintyre PE SD, Schug SA, Visser EJ, Walker SM, editors. Acute pain management: scientific evidence. Melbourne: Australian and New Zealand College of Anaesthetists and Faculty of Pain Medicine; 2010.p. 35-43

View Document

Document Type: Textbook

Candido KD, Winnie AP. Intravenous regional block for upper \& lower extremity surgery. In: Hadzic A, editor. Textbook of regional anesthesia and acute pain management. New York: McGraw-Hill; 2007. p. 565-78

View Document

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

IndonesiaUAnes005

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.